⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for siplizumab

Every month we try and update this database with for siplizumab cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Phase 1 Trial of Siplizumab and Dose-Adjusted EPOCH-Rituximab in T- and NK-Cell LymphomasNCT01445535
T-Cell Peripher...
Gamma Delta Hep...
Subcutaneous Pa...
NK T-Cell Lymph...
Rituximab
Etoposide
Siplizumab
Prednisone
Vincristine
Cyclophosphamid...
Doxorubicin
18 Years - 120 YearsNational Institutes of Health Clinical Center (CC)
Phase 1 Trial of Siplizumab and Dose-Adjusted EPOCH-Rituximab in T- and NK-Cell LymphomasNCT01445535
T-Cell Peripher...
Gamma Delta Hep...
Subcutaneous Pa...
NK T-Cell Lymph...
Rituximab
Etoposide
Siplizumab
Prednisone
Vincristine
Cyclophosphamid...
Doxorubicin
18 Years - 120 YearsNational Institutes of Health Clinical Center (CC)
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: